 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Magenta Therapeutics Inc. (MGTA)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-12-02 Sale | 2019-12-02 8:29 pm | Magenta Therapeutics Inc. | MGTA | COOKE MICHAEL P. Chief Scientific Officer | 7,500 | $13 | $97,520 | 240,523 (Direct) | View |
| 2019-12-09 Sale | 2019-12-11 4:03 pm | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 21,669 | $15 | $325,035 | 8,304 (Direct) | View |
| 2019-12-10 Sale | 2019-12-13 5:08 pm | Magenta Therapeutics Inc. | MGTA | GARDNER JASON Director | 4,392 | $15.1 | $66,319 | 344,820 (Indirect Direct) | View |
| 2019-12-20 Sale | 2019-12-20 5:52 pm | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 919 | $15 | $13,785 | 8,304 (Direct) | View |
| 2019-12-20 Sale | 2019-12-20 6:22 pm | Magenta Therapeutics Inc. | MGTA | GARDNER JASON Director | 76,711 | $15.16 | $1,162,617 | 268,109 (Indirect Direct) | View |
| 2019-12-23 Sale | 2019-12-23 4:41 pm | Magenta Therapeutics Inc. | MGTA | GARDNER JASON Director | 2,897 | $15.1 | $43,755 | 265,212 (Indirect Direct) | View |
| 2019-12-23 Sale | 2019-12-26 10:12 am | Magenta Therapeutics Inc. | MGTA | ISACSON CHRISTINA K. Chief Business Officer | 9,867 | $16.03 | $158,168 | 88,249 (Direct) | View |
| 2019-12-23 Sale | 2019-12-26 10:13 am | Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks | 4,181 | $16.03 | $67,021 | 135,911 (Direct) | View |
| 2019-12-24 Sale | 2019-12-26 4:11 pm | Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks | 7,902 | $16 | $126,432 | 128,009 (Direct) | View |
| 2019-12-24 Sale | 2019-12-26 4:12 pm | Magenta Therapeutics Inc. | MGTA | ISACSON CHRISTINA K. Chief Business Officer | 4,463 | $16.01 | $71,453 | 83,786 (Direct) | View |
| 2019-12-23 Sale(A) | 2019-12-30 5:39 pm | Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks | 12,083 | $16.01 | $193,473 | 133,010 (Direct) | View |
| 2020-01-02 Sale | 2020-01-03 4:01 pm | Magenta Therapeutics Inc. | MGTA | GARDNER JASON Director | 2,800 | $15.1 | $42,280 | 262,412 (Indirect Direct) | View |
| 2020-01-02 Sale | 2020-01-03 4:01 pm | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 11,294 | $15.04 | $169,817 | 8,304 (Direct) | View |
| 2020-01-10 Sale | 2020-01-10 5:01 pm | Magenta Therapeutics Inc. | MGTA | GARDNER JASON Director | 11,200 | $15.25 | $170,800 | 251,212 (Indirect Direct) | View |
| 2020-06-29 Purchase | 2020-07-01 4:48 pm | Magenta Therapeutics Inc. | MGTA | Booth Bruce Director | 1,250,000 | $8 | $10,000,000 | 1,250,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-12-09 Exercise | 2019-12-11 4:03 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 4,614 | $9.49 | 12,918 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 4:03 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 17,055 | $9.49 | 25,359 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 4:03 pm | N/A 2028-04-25 | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 4,614 | $0 | 254,099 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 4:03 pm | N/A 2028-04-25 | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 17,055 | $0 | 237,044 (Direct) | View |
| 2019-12-20 Exercise | 2019-12-20 5:52 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 114 | $9.49 | 8,418 (Direct) | View |
| 2019-12-20 Exercise | 2019-12-20 5:52 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 805 | $9.49 | 9,223 (Direct) | View |
| 2019-12-20 Exercise | 2019-12-20 5:52 pm | N/A 2028-04-25 | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 805 | $0 | 236,239 (Direct) | View |
| 2019-12-20 Exercise | 2019-12-20 5:52 pm | N/A 2028-04-25 | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 114 | $0 | 236,125 (Direct) | View |
| 2019-12-23 Exercise | 2019-12-30 5:39 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks | 9 | $7.71 | 140,101 (Direct) | View |
| 2019-12-23 Exercise | 2019-12-30 5:39 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks | 4,172 | $9.49 | 144,273 (Direct) | View |
| 2019-12-23 Exercise | 2019-12-30 5:39 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks | 820 | $7.71 | 140,912 (Direct) | View |
| 2019-12-23 Exercise | 2019-12-30 5:39 pm | N/A 2028-05-08 | Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks | 4,172 | $0 | 129,342 (Direct) | View |
| 2019-12-23 Exercise | 2019-12-30 5:39 pm | N/A 2028-01-30 | Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks | 9 | $0 | 17,676 (Direct) | View |
| 2019-12-23 Exercise | 2019-12-30 5:39 pm | N/A 2028-01-30 | Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks | 820 | $0 | 16,856 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-03 4:01 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 11,294 | $9.49 | 19,598 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-03 4:01 pm | N/A 2028-04-25 | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 11,294 | $0 | 224,831 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:07 pm | N/A 2030-02-09 | Magenta Therapeutics Inc. | MGTA | GARDNER JASON Director | 275,000 | $0 | 275,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:11 pm | N/A 2030-02-09 | Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:12 pm | N/A 2030-02-09 | Magenta Therapeutics Inc. | MGTA | ISACSON CHRISTINA K. Chief Business Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:15 pm | N/A 2030-02-09 | Magenta Therapeutics Inc. | MGTA | Ryan Jason See Remarks | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:19 pm | N/A 2030-02-09 | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 104,000 | $0 | 104,000 (Direct) | View |
| 2020-04-14 Option Award | 2020-04-16 4:52 pm | N/A 2030-04-13 | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR See Remarks | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-09 4:21 pm | N/A 2030-06-04 | Magenta Therapeutics Inc. | MGTA | Albers Jeffrey W. Director | 18,188 | $0 | 18,188 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-09 4:22 pm | N/A 2030-06-04 | Magenta Therapeutics Inc. | MGTA | Scadden David Director | 18,188 | $0 | 18,188 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-09 4:25 pm | N/A 2030-06-04 | Magenta Therapeutics Inc. | MGTA | Daniel Thomas O Director | 18,188 | $0 | 18,188 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-09 4:25 pm | N/A 2030-06-04 | Magenta Therapeutics Inc. | MGTA | McGeorge Anne Director | 18,188 | $0 | 18,188 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-09 4:25 pm | N/A 2030-06-04 | Magenta Therapeutics Inc. | MGTA | Booth Bruce Director | 18,188 | $0 | 18,188 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-09 4:26 pm | N/A 2030-06-04 | Magenta Therapeutics Inc. | MGTA | BONNEY MICHAEL W Director | 18,188 | $0 | 18,188 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-09 4:26 pm | N/A 2030-06-04 | Magenta Therapeutics Inc. | MGTA | RONNEBERG AMY L Director | 18,188 | $0 | 18,188 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-09 4:30 pm | N/A 2030-06-04 | Magenta Therapeutics Inc. | MGTA | BYERS BLAKE Director | 18,188 | $0 | 18,188 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-09 4:32 pm | N/A 2030-06-04 | Magenta Therapeutics Inc. | MGTA | Borisy Alexis Director | 18,188 | $0 | 18,188 (Direct) | View |
| 2020-09-14 Option Award | 2020-09-16 4:37 pm | N/A 2030-09-13 | Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks | 120,000 | $0 | 120,000 (Direct) | View |
| 2020-11-02 Option Award | 2020-11-04 4:39 pm | N/A 2030-11-01 | Magenta Therapeutics Inc. | MGTA | Mahoney Stephen F. See Remarks | 435,000 | $0 | 435,000 (Direct) | View |
| 2020-12-22 Option Award | 2020-12-23 7:13 pm | N/A 2030-12-21 | Magenta Therapeutics Inc. | MGTA | Lawton Alison Frances Director | 36,377 | $0 | 36,377 (Direct) | View |
| 2021-02-11 Option Award | 2021-02-16 5:42 pm | N/A 2031-02-10 | Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer | 67,500 | $0 | 67,500 (Direct) | View |
| 2021-02-11 Option Award | 2021-02-16 5:46 pm | N/A 2031-02-10 | Magenta Therapeutics Inc. | MGTA | GARDNER JASON Director | 112,500 | $0 | 112,500 (Direct) | View |
| 2021-02-11 Option Award | 2021-02-16 5:47 pm | N/A 2031-02-10 | Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks | 67,700 | $0 | 67,700 (Direct) | View |
| 2021-02-11 Option Award | 2021-02-16 5:48 pm | N/A 2031-02-10 | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR See Remarks | 72,500 | $0 | 72,500 (Direct) | View |
| 2021-02-11 Option Award | 2021-02-16 5:58 pm | N/A 2031-02-10 | Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-02-11 Other | 2021-02-16 6:15 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Atlas Venture Fund X L.P. 10% Owner | 968,726 | $0 | 3,148,399 (Direct) | View |
| 2021-04-19 Option Award | 2021-04-20 5:04 pm | N/A 2031-04-18 | Magenta Therapeutics Inc. | MGTA | Nichols David Wayne CTO | 175,000 | $0 | 175,000 (Direct) | View |